PharmaCyte Biotech, Inc. SEC filings PMCB
PharmaCyte Biotech, Inc. has 472 filings in SEC EDGAR's recent list, going back to Aug 20, 2001. Its latest annual report, Form 10-K, was filed on Jul 29, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (auditor change). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Extension | Dec 15, 2025 | Oct 31, 2025 |
| EFFECT | Filing | Sep 26, 2025 | — |
| CORRESP | Letter to the SEC | Sep 24, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2025 | — |
| D | Filing | Sep 4, 2025 | — |
| NT 10-K | Extension | Jul 29, 2025 | Apr 30, 2025 |
| NT 10-Q | Extension | Sep 17, 2024 | Jul 31, 2024 |
| NT 10-K | Form 12b-25 | Jul 29, 2024 | Apr 30, 2024 |
| EFFECT | Filing | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| NT 10-Q | Form 12b-25 | Sep 15, 2023 | Jul 31, 2023 |
| CORRESP | Letter to the SEC | Aug 4, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2023 | — |
| SC TO-I/A | Filing | Jun 15, 2023 | — |
| CORRESP | Letter to the SEC | Jun 5, 2023 | — |
| CORRESP | Letter to the SEC | May 30, 2023 | — |
| UPLOAD | Letter from the SEC | May 19, 2023 | — |
| SC TO-I | Schedule to-i | May 11, 2023 | — |
| DFAN14A | Filing | Jul 28, 2022 | — |
| PREC14A | Filing | Jul 26, 2022 | — |
| DFAN14A | Filing | Jul 11, 2022 | — |
| DFAN14A | Filing | Jul 5, 2022 | — |
| DFAN14A | Filing | Jun 23, 2022 | — |
| EFFECT | Filing | Nov 17, 2021 | — |
| CORRESP | Letter to the SEC | Nov 15, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2021 | — |
| D | Filing | Sep 1, 2021 | — |
| CERT | 8a cert | Aug 10, 2021 | — |
| 8-A12B | Registration of certain classes of securities | Aug 2, 2021 | — |
| NT 10-K | Notice of late filing | Jul 29, 2021 | Apr 30, 2021 |
| EFFECT | Filing | Apr 14, 2021 | — |
| CORRESP | Letter to the SEC | Apr 12, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2021 | — |
| NT 10-K | Extension | Jul 29, 2020 | Apr 30, 2020 |
| NT 10-Q | Extension | Dec 16, 2019 | Oct 31, 2019 |
| NT 10-K | Notice of late filing | Jul 29, 2019 | Apr 30, 2019 |
| UPLOAD | Letter from the SEC | Nov 6, 2017 | — |
| EFFECT | Filing | Sep 28, 2017 | — |
| CORRESP | Letter to the SEC | Sep 26, 2017 | — |
| NT 10-K | Form 12b-25 (nt 10-k) | Jul 14, 2016 | Apr 30, 2016 |
| UPLOAD | Letter from the SEC | Mar 3, 2016 | — |
| CORRESP | Letter to the SEC | Feb 2, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2016 | — |
| D | Filing | Jan 19, 2016 | — |
| NT 10-K | Notice of late filing | Jul 14, 2015 | Apr 30, 2015 |
| CT ORDER | Filing | Jan 20, 2015 | — |
| EFFECT | Filing | Oct 28, 2014 | — |
| CT ORDER | Filing | Oct 15, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2014 | — |
| CORRESP | Letter to the SEC | Oct 6, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2014 | — |
| CORRESP | Letter to the SEC | Sep 12, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2014 | — |
| CORRESP | Letter to the SEC | Aug 15, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2014 | — |
| NT 10-K | Notice of late filing | Jul 30, 2014 | Apr 30, 2014 |
| CORRESP | Letter to the SEC | Jul 11, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2014 | — |
| CORRESP | Letter to the SEC | May 27, 2014 | — |
| CORRESP | Letter to the SEC | May 5, 2014 | — |
| CORRESP | Letter to the SEC | May 2, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2014 | — |
| D | Filing | Dec 27, 2013 | — |
| NT 10-Q | Filing | Mar 18, 2013 | Jan 31, 2013 |
| 425 | 8-k | Feb 15, 2013 | — |
| NT 10-Q | Filing | Dec 17, 2012 | Oct 31, 2012 |
| NT 10-Q | Filing | Sep 14, 2012 | Jul 31, 2012 |
| NT 10-K | Form nt-10k | Jul 30, 2012 | Apr 30, 2012 |
| NT 10-Q | Nt-10q | Mar 19, 2012 | Jan 31, 2012 |
| UPLOAD | Letter from the SEC | Mar 1, 2012 | — |
| CORRESP | Letter to the SEC | Feb 28, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2012 | — |
| NT 10-Q | Nt-10q | Sep 14, 2011 | Jul 31, 2011 |
| NT 10-K | Nt-10k | Aug 1, 2011 | Apr 30, 2011 |
| UPLOAD | Letter from the SEC | Jun 20, 2011 | — |
| CORRESP | Letter to the SEC | Jun 8, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2011 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2011 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2011 | — |
| CORRESP | Letter to the SEC | Apr 27, 2011 | — |
| CORRESP | Letter to the SEC | Apr 27, 2011 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2011 | — |
| CORRESP | Letter to the SEC | Mar 2, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 15, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2011 | — |
| CORRESP | Letter to the SEC | Jan 31, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2011 | — |
| NT 10-Q | Filing | Dec 16, 2010 | Oct 31, 2010 |
| NTN 10Q | Filing | Nov 12, 2010 | Jul 31, 2010 |
| CORRESP | Letter to the SEC | Sep 28, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2010 | — |
| NT 10-K | Quarterly report | Jul 30, 2010 | Apr 30, 2010 |
| UPLOAD | Letter from the SEC | Mar 30, 2010 | — |
| CORRESP | Letter to the SEC | Mar 26, 2010 | — |
| CORRESP | Letter to the SEC | Mar 18, 2010 | — |
| NT 10-Q | Notification of late filing | Mar 18, 2010 | Jan 31, 2010 |
| UPLOAD | Letter from the SEC | Mar 11, 2010 | — |
| NT 10-Q | Filing | Dec 14, 2009 | Oct 31, 2009 |
| NT 10-K | Filing | Jul 29, 2009 | Apr 30, 2009 |
| 10KSB | Filing | Jul 29, 2008 | Apr 30, 2008 |
| 10QSB | Optional form for quarterly and transition reports of small business issuers | Mar 17, 2008 | Jan 31, 2008 |
| 10QSB | Optional form for quarterly and transition reports of small business issuers | Dec 13, 2007 | Oct 31, 2007 |
| 10QSB | Quarterly report [section 13 or 15(d)] | Sep 14, 2007 | Jul 31, 2007 |
| 10KSB | Optional form for annual and transition reports of small business issuers [secti | Aug 7, 2007 | Apr 30, 2007 |
| NT 10-K | Notification of inability to timely file form 10-k 405, 10-k, 10-ksb 405, 10-k | Jul 30, 2007 | Apr 30, 2007 |
| UPLOAD | Letter from the SEC | Jun 28, 2007 | — |
| 10QSB | Filing | Mar 19, 2007 | Jan 31, 2007 |
| 10QSB | Filing | Dec 15, 2006 | Oct 31, 2006 |
| 10QSB | Filing | Sep 14, 2006 | Jul 31, 2006 |
| 10KSB | Filing | Aug 14, 2006 | Apr 30, 2006 |
| NT 10-K | Filing | Jul 31, 2006 | Apr 30, 2006 |
| 10QSB | Filing | Mar 17, 2006 | Jan 31, 2006 |
| 10QSB/A | Filing | Dec 16, 2005 | Oct 31, 2005 |
| 10QSB | Filing | Dec 15, 2005 | Oct 31, 2005 |
| 10QSB | Filing | Sep 14, 2005 | Jul 31, 2005 |
| 10KSB | Filing | Aug 15, 2005 | Apr 30, 2005 |
| NTN 10K | Filing | Aug 2, 2005 | Apr 30, 2005 |
| 10QSB | Filing | Mar 18, 2005 | Jan 31, 2005 |
| NT 10-Q | Filing | Mar 18, 2005 | Jan 31, 2005 |
| 10QSB | Filing | Dec 15, 2004 | Oct 31, 2004 |
| CORRESP | Letter to the SEC | Sep 23, 2004 | — |
| 10QSB/A | Filing | Sep 23, 2004 | Jul 31, 2004 |
| 10KSB/A | Filing | Sep 23, 2004 | Apr 30, 2004 |
| 10QSB/A | Filing | Sep 23, 2004 | Jan 31, 2004 |
| 10QSB/A | Filing | Sep 23, 2004 | Oct 31, 2003 |
| 10QSB/A | Filing | Sep 23, 2004 | Jul 31, 2003 |
| 10QSB | Filing | Sep 20, 2004 | Jul 31, 2004 |
| NT 10-Q | Filing | Sep 15, 2004 | Jul 31, 2004 |
| UPLOAD | Letter from the SEC | Sep 10, 2004 | — |
| SB-2 | Filing | Aug 20, 2004 | — |
| 10KSB | Filing | Aug 13, 2004 | Apr 30, 2004 |
| NT 10-K | Filing | Jul 30, 2004 | Apr 30, 2004 |
| 10QSB | Filing | Mar 15, 2004 | Jan 31, 2004 |
| 10QSB | Filing | Dec 15, 2003 | Oct 31, 2003 |
| 10QSB | Filing | Aug 26, 2003 | Jul 31, 2003 |
| 10KSB | Filing | May 28, 2003 | Apr 30, 2003 |
| 10QSB | Filing | May 28, 2003 | Jan 31, 2003 |
| SB-2/A | Filing | Feb 4, 2003 | — |
| SB-2/A | Amendment no. 3 | Dec 11, 2002 | — |
| SB-2/A | Filing | Apr 24, 2002 | — |
| SB-2/A | Filing | Jan 23, 2002 | — |
| SB-2 | Filing | Aug 20, 2001 | — |
Showing 142 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PMCB (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1157075
- Former names
- NUVILEX, INC. (until Jan 9, 2015); EFOODSAFETY COM INC (until Mar 17, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.